Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Bioaccumulation of blood long-chain fatty acids during hemodialysis

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
550kB
[thumbnail of Supplementary Material] Other (Supplementary Material)
63kB

Item Type:Article
Title:Bioaccumulation of blood long-chain fatty acids during hemodialysis
Creators Name:Liu, T., Dogan, I., Rothe, M., Reichardt, J., Knauf, F., Gollasch, M., Luft, F.C. and Gollasch, B.
Abstract:Long-chain fatty acids (LCFAs) serve as energy sources, components of cell membranes, and precursors for signaling molecules. Uremia alters LCFA metabolism so that the risk of cardiovascular events in chronic kidney disease (CKD) is increased. End-stage renal disease (ESRD) patients undergoing dialysis are particularly affected and their hemodialysis (HD) treatment could influence blood LCFA bioaccumulation and transformation. We investigated blood LCFA in HD patients and studied LCFA profiles in vivo by analyzing arterio-venous (A-V) LFCA differences in upper limbs. We collected arterial and venous blood samples from 12 ESRD patients, before and after HD, and analyzed total LCFA levels in red blood cells (RBCs) and plasma by LC-MS/MS tandem mass spectrometry. We observed that differences in arterial and venous LFCA contents within RBCs (RBC LCFA A-V differences) were affected by HD treatment. Numerous saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) n-6 showed negative A-V differences, accumulated during peripheral tissue perfusion of the upper limbs, in RBCs before HD. HD reduced these differences. The omega-3 quotient in the erythrocyte membranes was not affected by HD in either arterial or venous blood. Our data demonstrate that A-V differences in fatty acids status of LCFA are present and active in mature erythrocytes and their bioaccumulation is sensitive to single HD treatment.
Keywords:Exercise, Lipidomics, Erythrocytes, Fatty Acids, Chronic Kidney Disease, Hemodialysis
Source:Metabolites
ISSN:2218-1989
Publisher:MDPI
Volume:12
Number:3
Page Range:269
Date:21 March 2022
Official Publication:https://doi.org/10.3390/metabo12030269
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library